Compounds > olmesartan
Page last updated: 2024-09-04

olmesartan and ici 204,219

olmesartan has been researched along with ici 204,219 in 3 studies

Compound Research Comparison

Studies
(olmesartan)		Trials
(olmesartan)		Recent Studies (post-2010)
(olmesartan)		Studies
(ici 204,219)		Trials
(ici 204,219)		Recent Studies (post-2010) (ici 204,219)
84118555446310191

Protein Interaction Comparison

ProteinTaxonomyolmesartan (IC50)ici 204,219 (IC50)
Solute carrier family 22 member 2Homo sapiens (human)9.7
Epidermal growth factor receptorHomo sapiens (human)5.751
Adenosine receptor A3Homo sapiens (human)1.363
Cytochrome P450 2C9 Homo sapiens (human)2.2575
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)1.363
Thromboxane-A synthase Homo sapiens (human)3.81
Mitogen-activated protein kinase 3 Homo sapiens (human)4.376
Mitogen-activated protein kinase 1Homo sapiens (human)0.538
Bifunctional epoxide hydrolase 2Homo sapiens (human)2
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)1.363
Sodium/bile acid cotransporterHomo sapiens (human)6.5
Mitogen-activated protein kinase 14Homo sapiens (human)0.353
Cysteinyl leukotriene receptor 1Cavia porcellus (domestic guinea pig)0.002
Multidrug and toxin extrusion protein 2Homo sapiens (human)7.6
Multidrug and toxin extrusion protein 1Homo sapiens (human)1.3
Cysteinyl leukotriene receptor 2Homo sapiens (human)7.397
Cysteinyl leukotriene receptor 1Homo sapiens (human)0.0039

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ekins, S; Williams, AJ; Xu, JJ1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1

Other Studies

3 other study(ies) available for olmesartan and ici 204,219

ArticleYear
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7

    Topics: Glutathione; Pharmacology; Sulfur Radioisotopes

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012